Rani Therapeutics to Participate in August Investor Conferences

Rhea-AI Summary

Rani Therapeutics (Nasdaq: RANI), a clinical-stage biotherapeutics company focusing on oral delivery of biologics and drugs, has announced its participation in two upcoming investor conferences in August 2024. The company will attend the BTIG Virtual Biotechnology Conference on August 5th-6th, participating in one-on-one investor meetings. Additionally, Rani will present at the Canaccord 44th Annual Growth Conference in Boston on August 13th at 3:30 PM ET, featuring a company presentation by CEO Talat Imran and investor meetings.

Interested parties can access live webcasts of these events through the 'Events' section of Rani Therapeutics' website. Webcast replays will be available after the presentations conclude.

SAN JOSE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in August 2024. These conferences include:

BTIG Virtual Biotechnology Conference
Location: Virtual
Date: Monday, August 5th – Tuesday, August 6th, 2024
Format: 1x1 Investor Meetings

Canaccord 44th Annual Growth Conference
Location: Intercontinental Hotel, Boston, MA
Date: Tuesday, August 13th, 2024 at 3:30pm E.T.
Format: Company Presentation and 1x1 Investor Meetings
Presenter: Chief Executive Officer, Talat Imran

Interested parties can register for and access the live webcasts for these conferences by visiting the “Events” section of the Rani Therapeutics website. The webcast replays will be available after the conclusion of the respective presentations.

About Rani Therapeutics

Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® capsule technology. For more information, visit ranitherapeutics.com.

Investor Contact:

investors@ranitherapeutics.com

Media Contact:

media@ranitherapeutics.com

FAQ

What investor conferences will Rani Therapeutics (RANI) attend in August 2024?

Rani Therapeutics will participate in two investor conferences in August 2024: the BTIG Virtual Biotechnology Conference on August 5th-6th and the Canaccord 44th Annual Growth Conference in Boston on August 13th.

When and where will Rani Therapeutics (RANI) present at the Canaccord Growth Conference?

Rani Therapeutics will present at the Canaccord 44th Annual Growth Conference on Tuesday, August 13th, 2024, at 3:30 PM ET. The conference will be held at the Intercontinental Hotel in Boston, MA.

Who will be presenting for Rani Therapeutics (RANI) at the Canaccord Growth Conference?

Talat Imran, the Chief Executive Officer of Rani Therapeutics, will be presenting at the Canaccord 44th Annual Growth Conference.

How can investors access the webcasts of Rani Therapeutics' (RANI) conference presentations?

Investors can access live webcasts of Rani Therapeutics' conference presentations by visiting the 'Events' section of the company's website. Webcast replays will be available after the presentations conclude.

What type of meetings will Rani Therapeutics (RANI) participate in at the BTIG Virtual Biotechnology Conference?

Rani Therapeutics will participate in one-on-one investor meetings at the BTIG Virtual Biotechnology Conference on August 5th-6th, 2024.